Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145967 | SCV000193112 | uncertain significance | Roberts-SC phocomelia syndrome | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001430181 | SCV001632911 | likely benign | not provided | 2023-09-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002514815 | SCV003591298 | uncertain significance | Inborn genetic diseases | 2021-12-07 | criteria provided, single submitter | clinical testing | The c.383G>A (p.G128E) alteration is located in exon 3 (coding exon 2) of the ESCO2 gene. This alteration results from a G to A substitution at nucleotide position 383, causing the glycine (G) at amino acid position 128 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001826798 | SCV002083238 | benign | Roberts syndrome | 2019-10-28 | no assertion criteria provided | clinical testing |